Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumours is a phase 3 interventional study registered as NCT06658353, led by Jiangsu vcare pharmaceutical technology co., and recruiting when checked on 2026-09-11. Official title: Single-arm, Open, Multi-centre Phase III Clinical Study to Assess the Safety and Effectiveness of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumours. Planned enrolment is 54 participants (estimated). The study started in 2025-03-17 and primary completion is expected in 2026-12-30. No results have been posted on ClinicalTrials.gov.